MediWound Ltd. (NASDAQ:MDWD) traded with a subtraction of -$0.35 to $1.40 on Thursday, a downside of -20.15 percent. An average of 156,902 shares of common stock have been traded in the last five days. There was a fall of -$0.4700 in the past week, and it reached a new high 4 times over the past 12 months. The last 20 days have seen an average of 126,821 shares traded, while the 50-day average volume stands at 93,334.
MDWD stock has decreased by -13.58% in the last month. The company shares reached their 1-month lowest point of $1.3300 on 09/22/22. With the stock rallying to its 52-week high on 01/07/22, shares of the company touched a low of $1.21 and a high of $4.01 in 52 weeks. It has reached a new high 3 times so far this year and lost -25.85% or -$0.9600 in price. In spite of this, the price is down -65.15% from the 52-week high.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now.
MediWound Ltd. (MDWD) stock’s beta is 0.97. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 2.79.
The quick ratio of MediWound Ltd. for the three months ended March 30 was 1.40, and the current ratio was 1.60, indicating that the company is able to meet its debt obligations. Its gross profit as reported stood at $8.77 million compared to revenue of $23.76 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, MediWound Ltd.’s return on assets was -68.40%.
For the three-month period that ended March 30, MediWound Ltd. had $5.0 million in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$9.2 million in the quarter, while revenues were grew 153.91%. The analyst consensus anticipated MediWound Ltd.’s latest quarter earnings to come in at -$0.11 per share, but it turned out to be -$0.12, a -9.10% surprise. For the quarter, EBITDA amounted to -$3.35 million.
From a technical analysis perspective, let’s take a brief look at MediWound Ltd. (MDWD) price momentum. RSI 9-day as of the close on 21 September was 13.92%, suggesting the stock is oversold, with historical volatility in this time frame at 107.92%.
As of today, MDWD’s price is $1.7100 -25.13% or -$0.4700 from its 5-day moving average. MDWD is currently trading -28.21% lower than its 20-day SMA and -33.96% lower than its 100-day SMA. However, the stock’s current price level is -21.35% below the SMA50 and -39.13% below the SMA200.
The stochastic %K and %D were 13.30% and 11.47%, respectively, and the average true range (ATR) was 0.1517. With the 14-day stochastic at 10.64% and the average true range at 0.1438, the RSI (14) stands at 22.99%. The stock has reached -0.1417 on the 9-day MACD Oscillator while the 14-day reading was at -0.1849.